Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Single-cell sequencing maps immune changes in chronic myeloid leukemia

Single-cell sequencing maps immune changes in chronic myeloid leukemia

Planned C-sections linked to increased risk of developing childhood leukemia

Planned C-sections linked to increased risk of developing childhood leukemia

Study reveals hidden cause of treatment failure in acute promyelocytic leukemia

Study reveals hidden cause of treatment failure in acute promyelocytic leukemia

TET2 mutations in blood stem cells linked to lower Alzheimer's risk

TET2 mutations in blood stem cells linked to lower Alzheimer's risk

Leukemia-on-a-chip offers breakthrough in personalized cancer treatment

Leukemia-on-a-chip offers breakthrough in personalized cancer treatment

Timepoint at which B cells transform into leukemic cells impacts treatment outcomes

Timepoint at which B cells transform into leukemic cells impacts treatment outcomes

Blood test can reveal early signs of leukemia without bone marrow sampling

Blood test can reveal early signs of leukemia without bone marrow sampling

Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia

Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia

Fusion genes found to be pivotal players in cancer development

Fusion genes found to be pivotal players in cancer development

Researchers turn a deadly fungus into potent cancer-fighting compound

Researchers turn a deadly fungus into potent cancer-fighting compound

Scientists identify novel combination therapy approach to treat pediatric acute myeloid leukemia

Scientists identify novel combination therapy approach to treat pediatric acute myeloid leukemia

Targeted nanoparticles enable in vivo production of CAR T cells for cancer therapy

Targeted nanoparticles enable in vivo production of CAR T cells for cancer therapy

New drug combination shows high remission rates in acute myeloid leukemia

New drug combination shows high remission rates in acute myeloid leukemia

High-fiber plant-based diet could benefit patients at risk for developing multiple myeloma

High-fiber plant-based diet could benefit patients at risk for developing multiple myeloma

First-in-class antibody-drug conjugate shows high response rates in rare blood cancer trial

First-in-class antibody-drug conjugate shows high response rates in rare blood cancer trial

Universal CAR T cell therapy shows promise for aggressive T cell cancers

Universal CAR T cell therapy shows promise for aggressive T cell cancers

New app can help improve quality of life for caregivers of bone marrow transplant patients

New app can help improve quality of life for caregivers of bone marrow transplant patients

Pitt professor wins NSF CAREER Award for AI-driven immunotherapy research

Pitt professor wins NSF CAREER Award for AI-driven immunotherapy research

Study highlights scholastic needs of adolescents and young adults with cancer

Study highlights scholastic needs of adolescents and young adults with cancer

Innovative technology simplifies T cell harvesting for cancer immunotherapy

Innovative technology simplifies T cell harvesting for cancer immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.